Civica Rx CEO Martin VanTrieste says Civica’s members are experiencing fewer shortages because of strategies used by the company.
Second of three parts
Drug shortages aren’t in the headlines as much as they were when Civica Rx was founded in 2018, CEO Martin VanTrieste says that lack of appearance may be deceiving.
“You don’t see it as much in the news because we’re focused on something else right now, called the pandemic,” VanTrieste said in an interview this week with Managed Healthcare Executive.
But in this segment of a wide-ranging interview conducted earlier this week, VanTrieste also says that Civic Rx’s members — which now include 50 healthcare systems comprising roughly 1,500 hospitals — are experiencing fewer shortages because Civica’s strategies have alleviated the problem. The strategies include strategic stockpiling and redundant suppliers.
Moreover, earlier this year, Civica announced that it was constructing a manufacturing facility in Petersburg, Virginia.
In another part of the interview, VanTrieste said it is currently supplying 60 drugs to hospitals is aiming to increase that number to 100 within the first five years of the company’s existence, or 2023,
In this segment, VanTrieste also discussed the three tiers of Civica’s membership program. “Partnering members” on the lowest tier pay $300 per licensed hospital bad “so it’s very affordable to a community hospital,” VanTrieste said. In some cases, the organization may waive the one-time fee. Hospitals also pay Civica for the drugs they buy.
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
April 22nd 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
Joseph Zabinski Advocates for Patient Trust in AI Adoption in Dermatology Care
April 18th 2024Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1, chatted with MHE editors on the significance of patient acceptance in AI adoption in healthcare, overall and in the dermatology space, stressing trust and transparency.
Read More